Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Baronio, Diego, Taylor Gonchoroski, Kamila Castro, Geancarlo Zanatta, Carmem Gottfried, and Rudimar Riesgo. "Histaminergic system in brain disorders: lessons from the translational approach and future perspectives." Annals of general psychiatry 13, no. 1 (2014): 1-10. |
|
Prasad, Konasale M., Catherine H. Upton, Vishwajit L. Nimgaonkar, and Matcheri S. Keshavan. "Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study." Schizophrenia research 161, no. 1 (2015): 119-125. |
|
Mikulska, Joanna, Gabriela Juszczyk, Monika Gawro?ska-Grzywacz, and Mariola Herbet. "HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation." Brain Sciences 11, no. 10 (2021): 1298. |
|
Yin, John, Alasdair M Barr, Alfredo Ramos-Miguel, and Ric M Procyshyn. "Antipsychotic induced dopamine supersensitivity psychosis: a comprehensive review." Current neuropharmacology 15, no. 1 (2017): 174-183. |
|
Chen, Xin, John D. McCorvy, Matthew G. Fischer, Kyle V. Butler, Yudao Shen, Bryan L. Roth, and Jian Jin. "Discovery of G protein-biased D2 dopamine receptor partial agonists." Journal of medicinal chemistry 59, no. 23 (2016): 10601-10618. |
|
Vincenzi, Brenda, Shannon Stock, Christina PC Borba, Sarah M. Cleary, Claire E. Oppenheim, Liana J. Petruzzi, Xiaoduo Fan et al. "A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism." Schizophrenia research 159, no. 2-3 (2014): 395-403. |
|
Ganji, Rasoul, Shahnaz Razavi, Nazem Ghasemi, and Mohammad Mardani. "Improvement of Remyelination in Demyelinated Corpus Callosum Using Human Adipose-Derived Stem Cells (hADSCs) and Pregnenolone in the Cuprizone Rat Model of Multiple Sclerosis." Journal of Molecular Neuroscience 70, no. 7 (2020): 1088-1099. |
|
Baldessarini, Ross J. "Antipsychotic agents." In Chemotherapy in Psychiatry, pp. 31-88. Springer, New York, NY, 2013. |
|
Di Sciascio, Guido, and Marco Andrea Riva. "Aripiprazole: from pharmacological profile to clinical use." Neuropsychiatric disease and treatment 11 (2015): 2635. |
|
Nguyen, Tanya T., Lisa T. Eyler, and Dilip V. Jeste. "Systemic biomarkers of accelerated aging in schizophrenia: a critical review and future directions." Schizophrenia bulletin 44, no. 2 (2018): 398-408. |
|
Fazari, Benedetta, Cvetana Ilieva Decheva, Victoria Gonzalez Garcia, Laila Abdel?Hafiz, Susanne Nikolaus, Cornelis P. Hollenberg, Joseph P. Huston, Maria A. de Souza Silva, and Claudia Mattern. "Intranasal pregnenolone increases acetylcholine in frontal cortex, hippocampus, and amygdala—Preferentially in the hemisphere ipsilateral to the injected nostril." Journal of neurochemistry 153, no. 2 (2020): 189-202. |
|
Stevens, Georgia L., Gail Dawson, and Jacqueline Zummo. "Clinical benefits and impact of early use of long?acting injectable antipsychotics for schizophrenia." Early intervention in psychiatry 10, no. 5 (2016): 365-377. |
|
Kharkwal, Geetika, Karen Brami-Cherrier, José E. Lizardi-Ortiz, Alexandra B. Nelson, Maria Ramos, Daniel Del Barrio, David Sulzer, Anatol C. Kreitzer, and Emiliana Borrelli. "Parkinsonism driven by antipsychotics originates from dopaminergic control of striatal cholinergic interneurons." Neuron 91, no. 1 (2016): 67-78. |
|
Zakharyan, Roksana, and Anna Boyajyan. "Inflammatory cytokine network in schizophrenia." The World Journal of Biological Psychiatry 15, no. 3 (2014): 174-187. |
|
Calzavara, Mariana Bendlin, Raquel Levin, Wladimir Agostini Medrano, Valéria Almeida, Antônio Pereira Fróis Sampaio, Lucas Cerqueira Barone, Roberto Frussa-Filho, and Vanessa Costhek Abílio. "Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats." Behavioural brain research 225, no. 1 (2011): 15-22. |
|
Klemettilä, Jari-Pekka, Olli Kampman, Niko Seppälä, Merja Viikki, Mari Hämäläinen, Eeva Moilanen, and Esa Leinonen. "Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine." Psychiatry research 218, no. 3 (2014): 277-283. |
|
Miller, Brian J., Krystle L. Graham, Chelsea M. Bodenheimer, Nick H. Culpepper, Jennifer L. Waller, and Peter F. Buckley. "A prevalence study of urinary tract infections in acute relapse of schizophrenia." The Journal of clinical psychiatry 74, no. 3 (2013): 0-0. |
|
Jafari, Somayeh, Francesca Fernandez?Enright, and Xu?Feng Huang. "Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects." Journal of neurochemistry 120, no. 3 (2012): 371-384. |
|
Farb, David H. "Conor C. Smith, Terrell T. Gibbs &." Psychopharmacology 231 (2014): 3537-3556. |
|
Ferrando, Stephen J., Lidia Klepacz, Sean Lynch, Mohammad Tavakkoli, Rhea Dornbush, Reena Baharani, Yvette Smolin, and Abraham Bartell. "COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response?." Psychosomatics 61, no. 5 (2020): 551. |
|